Background: Abdominal aortic aneurysm (AAA) formation involves an inflammatory process with a strong genetic background. C-reactive protein (CRP) regulates inflammation and is elevated in patients with AAA. The aim of this study was to investigate the association of the triallelic (C, A, and T alleles) rs3091244 functional CRP single nucleotide polymorphism (SNP) with AAA. Methods: This was a case-control study involving two independent populations: 351 AAA patients (mean aortic diameter, 6.25 6 1.47 cm) and 391 controls (mean diameter, 2.4 6 0.2 cm) were recruited from Greece (the main cohort); and 371 patients (mean diameter, 5.4 6 1.0 cm) and 362 controls (mean diameter, 2.4 6 0.6 cm) were recruited from the United Kingdom (replication cohort). The frequency of the functional triallelic (C, T, and A alleles) rs3091244 polymorphism was analyzed in univariate and adjusted (for cardiovascular risk factors) analyses, assuming that the rare T and A alleles have similar functional properties (pooled analysis for T and A). Three groups were constructed: group A included those with the rare T and A alleles (genotypes TT, AA, and TA), group B included heterozygotes for the C allele (CT, CA), and group C included C allele homozygotes (CC, reference genotype). Finally, meta-analysis of the two populations was performed together with previously reported results. Results: Genotype distributions differed significantly between cases and controls in both cohorts (P < .001 and P [ .001). Adjusted analysis (for all aneurysm-related risk-factors) showed an estimated odds ratio of 4.88 (95% confidence interval [CI], 2.96-8.04) for SNP group A and 2.38 (95% CI, 1.69-3.36) for SNP group B (P < .001 in both cases) in the initial cohort and 2.07 (95% CI, 1.33-3.21) for SNP group A and 1.70 (95% CI, 1.21-2.39) for SNP group B (P [ .001 and .002) in the replication cohort. The SNP group A patients among the main cohort also had higher CRP levels (median, 26; interquartile range, 17-52 mg/L vs median, 4; interquartile range, 4-12 mg/L; P < .001). Aneurysms >5.5 cm were significantly more frequent among the SNP groups A and B compared with C allele homozygotes both in the main and the replication cohorts (P < .001 and P [ .001, respectively). Meta-analysis of the two populations with previously reported results showed a positive association between minor-allele and aneurysm presence with an odds ratio of 1.47 (95% CI, 1.01-2.14; I 2 [ 83.1%; P [ .04). Conclusions: The rare T and A alleles were significantly related with AAA presence in both populations and correlated with higher CRP levels and AAA diameter. (J Vasc Surg 2014;60:1332-9.) 
Abdominal aortic aneurysm (AAA) constitutes a significant health problem, with prevalence rates for men above the age of 65 ranging from 1.7% to 7.2%. [1] [2] [3] Several environmental factors are implicated in the formation of AAA, but the disease is also recognized to have a strong genetic component, based on epidemiologic studies. 4, 5 From Those with a first-degree relative with AAA may have up to an 11-fold increased risk of developing the disease themselves. 6 Previous reports have investigated functional and nonfunctional single nucleotide polymorphisms (SNPs) in patients with aneurysmal disease. 4, 7 However, the majority of the available literature has largely included patients with small aneurysms from nongeographically uniform populations and findings have not been validated in separate cohorts. Other investigators have followed a genomewide approach to identify potential genome targets. The reported odds ratios (ORs) for the identified risk alleles in these studies are not in agreement with the strong heritability pattern observed in epidemiologic studies and suggest that there are multiple risk loci associated with the disease with many yet to be identified. 8, 9 C-reactive protein (CRP) levels have been linked to cardiovascular disease prevalence. 10, 11 Additionally, CRP is known to induce the production of nitric oxide, regulate fibrinolysis, and alter the expression of inflammatory molecules and complement. 11, 12 These processes have been directly linked to AAA formation. 13 Previous investigators have attempted to link circulating levels of CRP with specific genetic polymorphisms. [14] [15] [16] A triallelic SNP (alleles C, T, and A) known as rs3091244 has been shown to independently correlate strongly with serum CRP levels and cardiovascular risk. 15, 16 The C allele is associated with low levels of CRP. The rare T and A alleles are both associated with high levels of CRP. 17 A recent study attempted to assess the prevalence of this SNP in patients with an AAA, documenting no significant differences between subjects and controls; however, this analysis included patients with mostly small aneurysms, and the findings have not been confirmed in independent populations. 14 The present case-control study investigates the role of the functional CRP polymorphism rs3091244 within the promoter region of the CRP gene in the formation of an AAA using two well characterized independent populations.
METHODS

Study populations
This is a case control study including two geographically discrete populations. The main population of the study is a group of patients undergoing endovascular or open repair of an infrarenal AAA between January 2008 and April 2011 in a tertiary referral center for general and vascular surgery in Northern Greece (cases) and a group of geographically matched controls with similar characteristics, without an AAA (maximal aortic diameter of 3.0 cm), recruited within the same time period from the same department. All individuals had provided written informed consent for participation in the study. All relevant clinical information (demographics, medication, medical history, family history, abdominal imaging) was prospectively recorded in an electronic registry. Both groups were Caucasian whites of Mediterranean origin. Patients with an AAA were eligible for repair if they had maximal aortic diameter >5 cm; maximal aortic diameter <5 cm with a rapidly increasing sac (exceeding 1 cm per year); and a symptomatic AAA. Patients with inflammatory aneurysms or soft-tissue pathologies (Marfan's syndrome or other pathology related with aneurysmatosis) were excluded. Control subjects were recruited from the same general surgical department and consisted of patients who had been admitted with an acute abdomen and had already undergone imaging of their abdominal aorta (computed tomography or arterial duplex) within the last 2 weeks before recruitment, documenting a maximal aortic diameter <3.0 cm. They were all consecutive patients of Greek origin. Patients with any aneurysm or soft-tissue disease were excluded from this group. No further exclusion criteria were applied. The study was approved by the institutional ethics committee.
A second group of patients and controls (validation cohort) from the United Kingdom was used to replicate the initial findings of the main study cohort. Samples were recruited from the Leicestershire regional screening program and the inpatient and outpatient populations of the Leicester regional Vascular Surgical Unit. The control group were screened for AAA by ultrasound (diameter <3.0 cm) and were all over 65 years of age but not selected in any other way. The patients and controls included in this study were consecutive individuals with adequate genetic material and available baseline demographics. No further exclusion criteria were applied. Genetic analyses DNA extraction. Peripheral venous blood was drawn into 5-mL ethylenediaminetetraacetic acid tubes upon recruitment and stored at À80 C until DNA was extracted using the QuickGene-810 system (Fujifilm, Singapore). Resulting DNA samples were stored at 4 C until analysis. Quality control for each batch of extractions was performed by running a blank tube through the whole process, omitting only the addition of blood. If any DNA was found in the blank tube, the whole DNA batch was rejected. Subject samples were identified by sample identification numbers, and clinical data were not available during genotyping.
Genotyping. The rs3091244 SNP was identified using LightSNip (TIB MOLBIOL GmbH, Berlin, Germany) on the Roche LightCycler 480 system (Roche Diagnostics Corporation, Indianapolis, Ind), which is based on real-time polymerase chain reaction and melting curve analysis. The reaction mixture contained 7.2 mL of polymerase chain reaction grade water, 0.5 mL of reagent mix (primers and probe), 1.0 mL of FastStart DNA Master and 0.8 mL of magnesium chloride (25 mM); 1.0 mL of DNA was used. The LightCycler 480 instrument was programmed as follows. Denaturation: 1 cycle at 95 C for 10 minutes, ramp rate ( C/s) 4.4, and acquisition mode none. Cycling: 45 cycles at 95 C for 10 seconds, ramp rate 4.4, and acquisition mode none; 60 C for 10 seconds, ramp rate 2.2, and acquisition mode single; and 72 C for 15 seconds, ramp rate 4.4, and acquisition mode none. Melting curve: 1 cycle at 95 C for 30 seconds, ramp rate 4.4, and acquisition mode none; 40 C for 2 minutes, ramp rate 1.5, and acquisition mode none; and 75 C for 0 seconds with continuous acquisition mode and 3 acquisitions per C. Cooling: 40 C for 30 seconds with a ramp rate of 1.5. The melting peaks were 55 C for C allele, 59 C for T allele, 62 C for A allele, and 57 C for heterozygous C/T. Serum CRP quantification and biochemical analyses. All biochemical analyses for the main cohort (cases and controls from Greece) were performed at baseline at the institution where the patients were recruited, prior to the repair of the AAA (part of preoperative assessment). Serum CRP levels were measured using nephelometry (Image 800 analyzer; Beckman Coulter, Brea, Calif). Full-blood count and white cell count were measured using a validated fully automated analyzer (CELL-DYN Sapphire analyzer; Abbott Laboratories, Abbott Park, Ill). Data were entered prospectively in an electronic database. Serum CRP levels or other baseline biochemistry results were not available for the second cohort (replication group) of the study, recruited from the United Kingdom.
Meta-analysis
A systematic electronic search of the literature was performed using the PubMed and Embase databases in December 2012. The following terms were used: "abdominal aortic aneurysm," "C-reactive protein," and "polymorphism." Only one article was identified that had previously investigated the rs3091244 polymorphism in individuals with and without AAA. Subsequently, results from this study, together with the results from our two cohorts were meta-analyzed to assess the overall effect of the SNP in AAA presence.
Statistical analysis
Analyses were performed using the Statistical Package for Social Sciences v. 17.0 (SPSS, Chicago, Ill). Deviation from the Hardy-Weinberg equilibrium was calculated using the c 2 test for all study populations. Continuous normally distributed data are presented as mean value 6 standard deviation, non-normally distributed data are presented as median and interquartile range (IQR), and categorical data are presented as absolute values and percentages. Differences between cases and controls at baseline were evaluated using Pearson's c 2 test for categorical variables and Student t-test for continuous variables. With regards to analyses of the triallelic rs3091244 SNP, we collapsed the rare T and A alleles because of their identical functional properties, as in previous studies [18] [19] [20] and used the CC genotype as the reference genotype. Three SNP groups were constructed; group A included those bearing the rare T and A alleles (genotypes AA, TT, and TA), group B included heterozygotes for the C allele (CT, CA), and group C included C allele homozygotes (CC, reference genotype). Baseline differences between SNP groups A, B, and C for continuous normally distributed variables were evaluated using one-way analysis of variance and the Kruskal-Wallis test for non-normally distributed variables. Adjusted analyses (logistic regression) were performed using all established AAA risk-factors 21 : age, sex, smoking, hypertension, history of myocardial infarction (MI), hypercholesterolemia, and diabetes, to assess the effect of the rs3091244 genotype on AAA presence. Correlation between aortic size and CRP concentration was tested using Spearman rank correlation coefficient. To meta-analyze the data from the two geographically discrete populations together with the results reported by Badger et al, 14 we used a random-effects model and calculated the randomsummary OR with a 95% confidence interval (CI), by using inverse-variance method. Meta-analysis was performed using R version 2.15 for Windows. Heterogeneity was assessed by using the I 2 statistic and Cochrane Q test. A P value of < .05 was considered significant. Initial power calculations to assess the necessary size of the populations was based on the minor-allele frequencies observed in the main study cohort (0.25 and 0.44) during the pilot stage of the study and a power of at least 90% with an a of 0.05 was chosen. The size of the main cohort was sufficient to detect differences at a 5% (a ¼ .05) significance level with 99% power and the size of the replication cohort was sufficient to detect differences with 75% power (a ¼ .05). Table I summarizes baseline characteristics for the  main cohort and Table II summarizes the prevalence of AAA among the three different SNP groups. The minor T and A alleles were significantly more common among those with aneurysmal disease (OR, 2.15; 95% CI, 1.73-2.67; P < .001) (Table II) . Logistic regression analysis, adjusted for age, sex, smoking, hypertension, hypercholesterolemia, history of MI, and diabetes showed an estimated OR of 4.88 (95% CI, 2.96-8.04) for SNP group A and 2.38 (95% CI, 1.69-3.36) for SNP group B (P < .001 in both cases) with regards to AAA presence in the main cohort (Tables III and IV) . The SNP group A patients had significantly higher CRP levels, compared with heterozygotes and homozygotes for the C allele (median, 26; IQR, 17-52 mg/L vs median, 4; IQR, 3-12 mg/L; P < .001; Table V), within the AAA group. The size of the AAA was also correlated with baseline serum CRP levels within the AAA group (Spearman's rho correlation coefficient, 0.317; P < .001). Aneurysms with a diameter >5.5 cm were significantly more frequent among the SNP group A (Table VI) . In fact, 48% of patients with an AAA >6.5 cm had a TT, AA, or TA genotype as opposed to 27% of those with an AAA <5.5 cm (P < .001).
RESULTS
The
The second cohort (replication group, from the United Kingdom) included 371 patients with an AAA (24 females [7%], mean age, 72 6 7 years; mean aortic diameter, 5.4 6 1 cm) and 362 controls (17 females [5%]; mean age, 71 6 7 years; mean aortic diameter, 2.4 6 0.6 cm) ( Table I ). These were predominantly white Caucasians of British origin. No deviation from the Hardy-Weinberg equilibrium was noted in this population (c 2 test; P ¼ .39 and .26 respectively). The minor T and A alleles were significantly more common among those with aneurysmal disease (OR, 1.47; 95% CI, 1.19-1.81; P ¼ .001; Table II ). Logistic regression analysis adjusted for age, sex, smoking, hypertension, hypercholesterolemia, history of MI, and diabetes showed an estimated OR of 2.07 (95% CI, 1.33-3.21) for SNP group A and 1.70 (95% CI, 1.21-2.39) for SNP group B (P ¼ .001 and .002) with regards to AAA presence in the replication cohort. Serum CRP levels were not available for this cohort. Aneurysms with a diameter >5.5 cm were again more frequent among the SNP groups A and B (Table VI) . Combined univariate analysis of the two cohorts (Greece and United Kingdom) showed that aneurysms >5.5 cm in diameter were more frequent among SNP groups A and B (P < .001).
Meta-analysis of the two populations together with the results reported by Badger et al 14 disclosed a positive association with regards to aneurysm presence with an OR of 1.47 (95% CI, 1.01-2.14; I 2 ¼ 83.1%; P ¼ .04; Fig ; Table VII) .
DISCUSSION
This case control study suggests that the triallelic CRP gene polymorphism rs3091244 may be related with the presence of an AAA in two geographically discrete populations, which is in contrast with previous findings.
14 Additionally, homozygotes for the rare T and A alleles in this analysis had significantly higher levels of CRP, supporting previous data that the polymorphism is indeed functional. 15, 16, 18 Significance was maintained after metaanalysis of the two populations together with previously reported results. 14 The pathophysiology of AAA formation is multifactorial, but there is strong epidemiologic evidence to suggest that the disease has a significant genetic component. 4 In an examination of 73,451 individuals with no previous history of AAA, Lederle et al 22 found family history to be one of the best predictors of AAA presence with an OR of 1.95 (95% CI, 1.56-2.43). Additionally, individuals with a firstdegree relative with AAA may have up to an 11-fold increased risk of developing an AAA. 6 As a result, several investigators assessed functional and nonfunctional SNPs in patients with an AAA, 4, 7 aiming to elucidate the genetic background of the disease. However, the majority of the available literature has largely included patients with small aneurysms, recruited from aneurysm screening programs, resulting in poorly characterized populations with regards to phenotype and associated risk-factor. Additionally, most findings have not been validated in independent cohorts. Other investigators have followed a genome-wide approach to identify potential genome targets; however, the reported ORs for the various identified risk alleles are not in agreement with the strong heritability pattern observed in epidemiologic studies, suggesting that there are multiple risk loci associated with the disease. 8, 9 CRP levels have been related to cardiovascular disease prevalence and outcomes in several populations. 10, 11 There is evidence that CRP may be implicated in inducing nitric oxide production, inhibit fibrinolysis, and alter the expression of the complement, processes involved in atheromatosis and aneurysm formation. 11, 12 Powell et al 23 were among the first to suggest a direct link between CRP levels and AAA presence, comparing 20 patients undergoing elective AAA repair and 20 controls with aortoiliac occlusive disease. 23 Vainas et al 24 measured highly sensitive CRP (hsCRP) in 39 patients with AAA and also detected CRP messenger RNA (mRNA) in the aneurysmal tissue of 16 patients. Serum hsCRP was associated with AAA presence and hsCRP levels correlated significantly with aortic size. CRP mRNA was found in 25% of aneurysmal aortic tissues, suggesting that CRP may be produced directly from the AAA. A meta-analysis of six studies comparing serum CRP levels between patients with AAA and controls (744 cases with AAA and 1288 controls without AAA) demonstrated significantly higher CRP concentration among the AAA group (pooled standardized mean difference: 0.50; 9% CI, 0.09-0.91; P ¼ .02). 25 Carlson et al 17 performed a systematic survey of the common nucleotide variations across the CRP gene and identified seven SNPs as functionally important; haplotype analysis revealed that the single most important SNP was the triallelic rs3091244. The C allele was associated with low levels of CRP. The rare T and A alleles were both associated with high levels of CRP. Various other studies have confirmed these findings with regards to the T and A alleles. 15, 16, 19, 20 Badger et al 14 have studied the rs3091244 SNP in relation to AAA presence using 227 individuals with an AAA and 277 controls. There was no statistical difference with regards to genotype between cases and controls at univariate analysis. No difference in CRP levels was demonstrated for each genotype. However, these results have not been validated in other populations, the number of patients included in the study was fairly small, the study did not analyze the minor T and A alleles combined (which have identical functional properties), and the AAA group included patients with small aneurysms (3.0-5.5 cm in diameter). Including a large amount of patients with an AAA close to 3.0 cm in diameter means that a significant proportion of that population may never develop an AAA that will require treatment; therefore, it is not of much clinical relevance. Additionally, by using a cut-off of 3.0 cm, a proportion of the control population may have an aorta close to 3.0 cm in diameter that may become aneurysmal in the future. This can be controlled by including larger AAAs in the study population.
The results of the current analysis are in contrast with these findings. Adjusted regression analysis showed an estimated OR of 4.90 (95% CI, 2.98-8.08) for those bearing the rare T and A alleles and 2.37 (95% CI, 1.68-3.34) for C allele heterozygotes (P < .001 in both cases) with regards to AAA presence. Similar findings were seen in the validation cohort, consisting of individuals from a different geographic region. It is interesting to note that both populations, even though they do derive from different geographical regions, are of European origin, which may be considered as a limitation of the study. However, the two cohorts did differ with regards to key characteristics that could be implicated in AAA formation and pose confounding factors in our analyses. More specifically, the second cohort of patients with aneurysmal disease consists (Table I) of slightly older patients with significantly higher rates of smoking and smaller AAAs. The rate of smoking history in the first cohort was actually low (73%; Table I ). The recruitment protocol was also different, with those in the first cohort having been recruited after referral for surgical management and those in the second cohort having been recruited predominantly from a screening program. We also documented that homozygotes for the rare T and A alleles have significantly higher CRP levels, which is in accordance with previous findings, suggesting that the rs3091244 SNP is indeed functional. Patients with larger aneurysms in the first cohort also had higher CRP levels. There may be an association with AAA growth and the SNP analyzed in this study; however, these higher levels of CRP among individuals with larger aneurysmal volumes may be secondary to the presence of a larger inflammatory infiltrate. The only way to investigate this etiologic role would be a study that follows up patients to assess AAA growth rates. Also, in our second cohort, most minor-allele homozygotes actually had an AAA of <5.5 cm (Table VI) . The main value, from a clinical standpoint, of this SNP is possibly not that of a "genetic screening marker." The minor-alleles are not very infrequent in the control populations (minor-allele frequencies of 0.44 vs 0.25 for cohort 1 and 0.48 vs 0.38 for cohort 2). This data mostly suggests that inflammation plays a key role in AAA formation, and there may be a genetic predisposition, partly related to the SNP that has been investigated here that drives this. Medication that targets this inflammatory process may be of crucial importance in AAA management in the future.
Limitations. This analysis bears some limitations that need to be mentioned. The second group of patients (validation cohort) was not prospectively recruited and CRP levels or other baseline biochemistry results were not available to replicate our initial biochemical findings. Additionally, aneurysmal tissue was not available to measure the levels of CRP mRNA and assess whether CRP was being produced directly by the AAA, which has been suggested in previous studies. Also, the two populations included in the study, even though they derive from two discrete geographical areas (Greece and United Kingdom), are both European. It would be of interest to further investigate the specific SNP in non-European populations.
CONCLUSIONS
Overall, this study suggests that the T and A alleles were related with AAA presence in two independent populations. Additionally, they correlated with higher CRP levels and AAA diameter. Further studies are required to validate these findings and elucidate the exact role of CRP and the specific polymorphism in AAA pathophysiology. 
